Skip to the lineages
Regenerative Medicine

How Can You Tell Whether a Regenerative Medicine Product Is FDA-Approved?

Published November 16, 2026

Protocol: 7 steps in this guide
  1. Step 1: Get the exact product name and manufacturer
  2. Step 2: Search FDA's records
  3. Step 3: Read the approved indication
  4. Step 4: Registration is not approval
  5. Step 5: IND, device clearance and licensure are different
  6. Step 6: Watch the dates on FDA pages
  7. Step 7: Keep a dated record

Check two things separately: whether FDA has approved the exact product, and whether the proposed use matches its approved labeling. Both answers are in FDA’s own records for the product’s exact name. An approved product used off-label is different from a product that FDA has never approved. Marketing words such as “FDA registered,” “FDA compliant” or “in a clinical trial” do not mean approved. FDA’s own patient notice states that the unapproved regenerative products it warns about “have not been approved for the treatment of any orthopedic condition,” although FDA has licensed a few cell-based products for specific surgical uses, such as MACI for certain knee cartilage defects in adults. A claim that a joint injection is FDA-approved should be checked against an FDA record before you rely on it.

Step 1: Get the exact product name and manufacturer

Approval belongs to a named product. Ask the clinic for:

  • the trade name, if any;
  • the proper (scientific) name;
  • the manufacturer;
  • the FDA document or license it says applies.

“Stem cells,” “exosomes” or “regenerative therapy” is not a product name. If a clinic cannot name the product, it cannot show you its approval.

Step 2: Search FDA’s records

For biological products, FDA’s Purple Book is a searchable database of licensed biologics. For cell and gene therapies, FDA also keeps a list of approved cellular and gene therapy products, with a page for each product. FDA’s consumer article Is It Really ‘FDA Approved’? also points readers to FDA’s list of licensed biological products and establishments. If the product is not there under any of its names, ask the clinic which FDA pathway it claims.

Step 3: Read the approved indication

Finding a product is only half the check. The approval covers a specific use, population and route. Two examples from FDA’s product pages:

Product Indication on FDA's product page
Ryoncil (remestemcel-L-rknd), Mesoblast, Inc. "Indicated for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months of age and older"
DUCORD (HPC, Cord Blood), Duke University School of Medicine Unrelated donor hematopoietic progenitor cell transplantation for disorders affecting the blood-forming system

Neither indication is a joint, tendon or spine condition. An approval for one use does not carry over to another; the Ryoncil product page and the DUCORD product page show exactly what each covers.

Step 4: Registration is not approval

FDA’s consumer article states: “Mere registration of an establishment or listing of a drug or device does not denote approval of the establishment, the drug or device, or other drugs or devices of the establishment, nor does it mean that a product may be legally marketed.” It also explains that FDA does not approve health care providers, including physician offices or laboratories. A registration number on a website is not evidence that a treatment is approved.

Step 5: IND, device clearance and licensure are different

Several FDA actions can be presented as if they were approval:

What the clinic says What it means
"We have an IND" FDA allowed a clinical investigation, or in narrow cases expanded access for a serious condition, to proceed; not approval for routine use
"The device is FDA cleared" A device, such as a processing machine, was cleared, for moderate-risk devices generally through 510(k); not approval of a treatment made with it
"We are FDA registered" The facility is registered; not approval
"Listed on ClinicalTrials.gov" A study is registered; not approval
"FDA approved for [condition]" Check the FDA record for that exact product and condition

Two of these are covered in detail: what it means when an FDA investigational new drug application is in effect and whether listing a study on ClinicalTrials.gov means a treatment is approved.

Step 6: Watch the dates on FDA pages

FDA pages are updated at different times. FDA’s Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes, current as of April 9, 2024, states that the only FDA-approved stem cell products are blood-forming stem cells derived from umbilical cord blood. On December 18, 2024, FDA announced its approval of Ryoncil, “the first FDA-approved MSC therapy.” The alert was correct when written and is now out of date on that point, though its warning that the products it names “have not been approved for the treatment of any orthopedic condition” still matches FDA’s patient information. Always check the “content current as of” date.

Step 7: Keep a dated record

Field Your entry
Date checked
Product name(s) given by the clinic
Manufacturer
Found in FDA's approved list or Purple Book?
Approved indication, word for word
Does it match your condition?
Pathway the clinic claims, if not approved

The same consumer alert, first dated July 22, 2020, asks anyone with questions about whether a regenerative medicine product is FDA-approved to call 800-835-4709 or email ocod@fda.hhs.gov, and FDA’s patient and consumer information on regenerative medicine therapies explains the risks of unapproved products. Product-specific checks are covered in whether A2M injection therapy is FDA-approved for arthritis and the FDA approval status of Muse cell therapies.

Two questions need separate answers: is the exact product FDA-approved, and does its approved indication match your condition? An approved product used for another condition is still an approved product used off-label, which FDA’s page on unapproved use of approved drugs describes as a prescriber’s medical judgment, and that is different from a product FDA has never approved.

A regenerative medicine product is FDA-approved only if FDA’s records list that exact product, and a use is on-label only if that product’s approved indication matches your condition, so registration numbers, device clearance, trial listings and older FDA pages should all be checked against the current product record before you treat a claim of approval as true.

Cells linked to this one

This guide leads on to

Guides that lead here

Lineage I: Patient Safety, Scientific Literacy and FDA Verification

What readers added

Add a remark

Your email address will not be published. Required fields are marked *